Proceedings of the Texas A&M Medical Student Grand Rounds

Heterozygous Variants of MEIS2 and Their Role in Cleft Lip/Palate, Congenital Heart Defects, and Intellectual Disability

July 17, 2025 Rithvik Gunda

Rithvik Gunda

Background: Mutations in the MEIS2 gene, located on chromosome 15q14, are associated with a triad of developmental conditions: cleft lip and/or palate, congenital heart defects, and intellectual impairment. MEIS2 is a member of the TALE (Three Amino Acid Loop Extension) homeobox gene family and acts as a transcription factor involved in early embryonic development. It has a very specific function in the regulation of neural crest cell migration and differentiation that forms craniofacial structures, cardiac tissue, and neural tracts. Haploinsufficiency of MEIS2, in which a single copy of the gene is inactivated or deleted, decreases its functional protein levels and causes disturbances in multiple developmental systems. Patients who carry MEIS2 variants experience a full spectrum of symptoms from delayed learning to outright heart defects and orofacial malformations.1, 2, 4

Objective: The aim of this review was to explore the mechanisms in which loss-of-function variants of MEIS2 produce the general triad of structural and cognitive abnormalities based on recent literature and from genetic, molecular, and clinical points of view.

Search Methods: PubMed was searched for publications between the years 2017 and 2023. The keywords used were “MEIS2,” “cleft palate,” “congenital heart disease,” “neurodevelopmental delay,” and “15q14 deletion.”

Results: MEIS2 plays a crucial role in the palatal shelf fusion occurring in embryogenesis. Without it, neural crest cells fail to populate the maxillary area properly, which results in structural abnormalities like cleft palate or bifid uvula.1, 3 Studies such as those conducted by Verheije et al. reported that more than 70% of individuals who suffered from MEIS2 haploinsufficiency exhibited some palatal abnormality.1 Cardiac abnormalities are also frequent, including ventricular and atrial septal defects as well as in some instances even more critical defects like persistent truncus arteriosus.1, 6 MEIS2 controls genes involved in cardiogenesis and also affects cardiac progenitor cell development when absent.2, 6 Within the brain, MEIS2 aids in neuron differentiation and maturation, especially in areas like the cerebral cortex and striatum.5 Loss-of-function mutations result in intellectual delay, attention-deficit disorder, and autism spectrum disorder features.1, 4 Animal models recapitulate human experience as cranial nerve development defects and profound brain growth and function deficits result from MEIS2 loss-of-function mutations.6

Conclusion: Heterozygous MEIS2 variants cause a multifaceted developmental syndrome affecting facial anatomy, heart development, and intellectual function. While treatment now focuses on treating single symptoms—e.g., cleft palate surgery or congenital heart correction—there’s a clear demand for holistic care approaches addressing the entire clinical profile.1, 4 Genetic counseling, early diagnosis and development screening, and treatment planning form a core set of interventions likely to enhance outcomes. Future efforts examining the correlation between specific MEIS2 mutations and severity of phenotype may inform personalized clinical and therapeutic plans. Understanding MEIS2 function in neural crest development and embryonic development will remain critical for the discovery of novel means of patient and family care in this syndrome.1, 2, 4, 6

Works Cited:

  1. Verheije R, Kupchik GS, Isidor B, et al. Heterozygous loss-of-function variants of MEIS2 cause a triad of palatal defects, congenital heart defects, and intellectual disability. Eur J Hum Genet. 2018;27(2):278-290. doi:10.1038/s41431-018-0281-5
  2. Miksiunas R, Mobasheri A, Bironaite D. Homeobox Genes and Homeodomain Proteins: New Insights into Cardiac Development, Degeneration and Regeneration. Adv Exp Med Biol. 2019:155-178. doi:10.1007/5584_2019_349
  3. Europe PMC. Europepmc.org. Published 2020. Accessed February 19, 2025. https://europepmc.org/article/pmc/7513377
  4. Leung RF, George AM, Roussel EM, Faux MC, Wigle JT, Eisenstat DD. Genetic Regulation of Vertebrate Forebrain Development by Homeobox Genes. Front Neurosci. 2022;16. doi:10.3389/fnins.2022.843794
  5. Larsen KB, Lutterodt MC, Laursen H, et al. Spatiotemporal Distribution of PAX6 and MEIS2 Expression and Total Cell Numbers in the Ganglionic Eminence in the Early Developing Human Forebrain. Dev Neurosci. 2010;32(2):149-162. doi:10.1159/000297602
  6. Machon O, Masek J, Machonova O, Krauss S, Kozmik Z. Meis2 is essential for cranial and cardiac neural crest development. BMC Dev Biol. 2015;15(1). doi:10.1186/s12861-015-0093-6
Cardiology Psychiatry
Previous Post

NF-κB Dysregulation Contributes to Cardiac Dysfunction in Duchenne Muscular Dystrophy Through Disrupted Calcium Handling

Next Post

Modulation of Androgen Receptor Expression in the Treatment of Amyotrophic Lateral Sclerosis

Scientific Editors

Steve A. Maxwell

Executive Editor
Tel: 979-436-0804
smaxwell@medicine.tamhsc.edu

Robin Fuchs-Young

Deputy Editor
Tel: 979-845-5109
fuchs-young@medicine.tamhsc.edu
Administrative Editor

Janis Chmiel

Tel: 979-436-0856
chmiel@medicine.tamhsc.edu
Editorial Office
Tel.: 979-845-2726
Fax: 979-847-9481
chmiel@medicine.tamhsc.edu
Archives
  • July 2026
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • May 2025
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • November 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • August 2022
  • June 2022
  • May 2022
  • August 2021
  • July 2021
  • April 2021
  • October 2020
  • August 2020
  • July 2020
  • August 2019
  • July 2019
  • February 2019
  • July 2018
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • January 2017
Proudly powered by WordPress | Theme: Fmi by Forrss.